Clinical Trials Directory

Trials / Completed

CompletedNCT07066865

Evaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease

Safety and Efficacy of Sutureless Dehydrated Amniotic Membrane (Omnigen) Mounted on Contact Lens (Omnilenz) for Ttt of Ocular Graft vs Host Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Farwaniya Hospital · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A case series of patients presented with graft versus host disease with ocular involvement . The study recruited a total of 3 patients who were referred to cornea clinic of Farwaniya Hospital, Kuwait between April 2022 and April 2024. All cases presented with severe dryness, spks and corneal epithelial defect not responding to other measures of treatment. An OmniLenz was applied for each patient for one week. Primary outcome measures included healing of the corneal resistant epithelial defect, secondary outcome measures were improvement of signs of dryness.

Conditions

Interventions

TypeNameDescription
DEVICEomniLenzsutureless dehydrated amniotic membrane (omnigen) mounted on contact lens (omnilenz)

Timeline

Start date
2022-04-01
Primary completion
2024-04-01
Completion
2024-04-01
First posted
2025-07-15
Last updated
2025-07-15

Locations

1 site across 1 country: Kuwait

Source: ClinicalTrials.gov record NCT07066865. Inclusion in this directory is not an endorsement.